| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
178,600,000 |
| Market
Cap: |
226.82(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.8901 - $1.85 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : 7.4 |
| Insider 3/6 Months : 8 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Precigen is a clinical-stage biopharmaceutical company improving gene and cell therapies. Co. is utilizing proprietary technology platforms to develop product candidates designed to diseases in its therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases. Co. is developing its clinical programs, including: PRGN-3005, PRGN-3006, and PRGN-3007, which are built on its UltraCAR-T platform; PRGN-2009 and PRGN-2012, which are based on its AdenoVerse immunotherapy platform; and AG019, which is built on its ActoBiotics platform. In addition, Co. has completed a Phase 1 study of INXN-4001, a non-viral triple-effector plasmid DNA, which is built on its UltraVector platform.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
96,686 |
1,592,031 |
13,134,243 |
| Total Buy Value |
$0 |
$136,327 |
$2,615,293 |
$22,822,494 |
| Total People Bought |
0 |
1 |
4 |
8 |
| Total Buy Transactions |
0 |
1 |
6 |
12 |
| Total Shares Sold |
0 |
96,686 |
455,706 |
719,367 |
| Total Sell Value |
$0 |
$136,327 |
$650,097 |
$1,021,712 |
| Total People Sold |
0 |
1 |
6 |
6 |
| Total Sell Transactions |
0 |
1 |
21 |
26 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Ares Trading S.a. |
10% Owner |
– – • |
2021-05-03 |
4 |
AS |
$7.47 |
$553,991 |
D/D |
(74,172) |
27,216,217 |
|
-15% |
|
| Ares Trading S.a. |
10% Owner |
– – • |
2021-04-30 |
4 |
AS |
$7.90 |
$853,740 |
D/D |
(108,130) |
27,290,389 |
|
-19% |
|
| Osborne D. Bradford |
VP, Finance and AccountingOffi |
• – – |
2021-04-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
60,380 |
|
-20% |
|
| Kirk Randal J |
Director |
– • • |
2021-03-25 |
4 |
A |
$7.71 |
$99,999 |
I/I |
12,970 |
18,329,996 |
|
- |
|
| Kindler Jeffrey B |
Director |
– • – |
2021-03-25 |
4 |
A |
$7.71 |
$68,997 |
D/D |
8,949 |
214,209 |
|
- |
|
| Frank Steven |
Director |
– • – |
2021-03-25 |
4 |
A |
$7.71 |
$49,999 |
D/D |
6,485 |
337,205 |
|
- |
|
| Alvarez Cesar L |
Director |
– • – |
2021-03-25 |
4 |
A |
$7.71 |
$62,497 |
D/D |
8,106 |
257,396 |
|
- |
|
| Hassan Fred |
Director |
– • – |
2021-03-25 |
4 |
A |
$7.71 |
$56,499 |
D/D |
7,328 |
154,687 |
|
- |
|
| Gupta Vinita D |
Director |
– • – |
2021-03-25 |
4 |
A |
$7.71 |
$56,499 |
D/D |
7,328 |
147,820 |
|
- |
|
| Shapiro Robert B |
Director |
– • – |
2021-03-25 |
4 |
A |
$7.71 |
$62,998 |
D/D |
8,171 |
193,911 |
|
- |
|
| Mitchell Dean J |
Director |
– • – |
2021-03-25 |
4 |
A |
$7.71 |
$56,499 |
D/D |
7,328 |
177,926 |
|
- |
|
| Turley James S |
Director |
– • – |
2021-03-25 |
4 |
A |
$7.71 |
$62,497 |
D/D |
8,106 |
159,904 |
|
- |
|
| Alvarez Cesar L |
Director |
– • – |
2021-03-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
62,189 |
249,290 |
|
- |
|
| Mitchell Dean J |
Director |
– • – |
2021-03-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
62,189 |
170,598 |
|
- |
|
| Frank Steven |
Director |
– • – |
2021-03-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
62,189 |
330,720 |
|
- |
|
| Turley James S |
Director |
– • – |
2021-03-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
62,189 |
151,798 |
|
- |
|
| Gupta Vinita D |
Director |
– • – |
2021-03-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
62,189 |
140,492 |
|
- |
|
| Kindler Jeffrey B |
Director |
– • – |
2021-03-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
62,189 |
205,260 |
|
- |
|
| Hassan Fred |
Director |
– • – |
2021-03-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
62,189 |
147,359 |
|
- |
|
| Shapiro Robert B |
Director |
– • – |
2021-03-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
62,189 |
185,740 |
|
- |
|
| Frank Steven |
Director |
– • – |
2021-03-03 |
4 |
OE |
$5.69 |
$16,888 |
D/D |
2,968 |
268,531 |
|
- |
|
| Alvarez Cesar L |
Director |
– • – |
2021-03-03 |
4 |
OE |
$5.69 |
$16,888 |
D/D |
2,968 |
187,101 |
|
- |
|
| Mitchell Dean J |
Director |
– • – |
2021-03-03 |
4 |
OE |
$5.69 |
$16,888 |
D/D |
2,968 |
108,409 |
|
- |
|
| Sabzevari Helen |
President and CEO |
• • – |
2021-01-06 |
4 |
AS |
$8.92 |
$2,318,535 |
D/D |
(260,045) |
655,214 |
|
-29% |
|
| Sabzevari Helen |
President and CEO |
• • – |
2021-01-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
500,000 |
915,259 |
|
- |
|
689 Records found
|
|
Page 10 of 28 |
|
|
0.02 (1.55%) 
